Lonza Biologics Tuas Overview
- Year Founded
-
2007

- Status
-
Private
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$6.48M
Lonza Biologics Tuas General Information
Description
Provider of a medical research and development services intended to offer large-scale cell culture manufacturing facilities. The company's medical research and development services offers a site for the production of monoclonal antibodies and recombinant proteins, enabling its clients to receive treatment related to large-scale cell culture.
Contact Information
Corporate Office
- 35 Tuas South Avenue 6
- Singapore, 637377
- Singapore
Corporate Office
- 35 Tuas South Avenue 6
- Singapore, 637377
- Singapore
Lonza Biologics Tuas Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 27-Aug-2008 | $6.48M | Completed | Generating Revenue | ||
2. Early Stage VC | Completed | Generating Revenue | ||||
1. Joint Venture | 01-Jan-2007 | Completed | Generating Revenue |
Lonza Biologics Tuas FAQs
-
When was Lonza Biologics Tuas founded?
Lonza Biologics Tuas was founded in 2007.
-
Where is Lonza Biologics Tuas headquartered?
Lonza Biologics Tuas is headquartered in Singapore, Singapore.
-
What industry is Lonza Biologics Tuas in?
Lonza Biologics Tuas’s primary industry is Biotechnology.
-
Is Lonza Biologics Tuas a private or public company?
Lonza Biologics Tuas is a Private company.
-
What is the current valuation of Lonza Biologics Tuas?
The current valuation of Lonza Biologics Tuas is
. -
What is Lonza Biologics Tuas’s current revenue?
The current revenue for Lonza Biologics Tuas is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »